Torrent Pharmaceuticals partner with Boehringer Ingelheim to co-market diabetes, cardiovascular medicines

Both companies entered into partnership for the sales and co-marketing of Empagliflozin and its combinations including Cospiaq (Empagliflozin), Cospiaq MetTM (Empagliflozin+ Metformin) and Xilingio (Empagliflozin+ Linagliptin) in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kWsLc1v
via IFTTT